paclitaxel has been researched along with Hypoalbuminemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iede, K; Ikenaga, M; Koh, M; Matsuyama, J; Nakashima, S; Ohta, K; Tanida, T; Tominaga, S; Tsuda, Y; Ueda, M; Yamada, T | 1 |
| Fan, J; Fan, W; Lin, B; Wang, Y; Yin, W; Zang, F; Zhou, F | 1 |
| Abrams, T; Aguirre, AJ; Bakir, B; Blaszkowsky, L; Brais, L; Chiarella, AM; Cleary, JM; Das, K; Enzinger, P; Germon, V; Giannakis, M; Giantonio, BJ; Goessling, W; Goyal, L; Horick, N; Meyerhardt, JA; Needle, M; Perez, K; Pitarresi, JR; Raghavan, S; Rubinson, D; Rustgi, AK; Stonely, D; Weekes, C; Wolpin, BM; Yurgelun, MB | 1 |
| Harada, D; Kageyama, A; Kawakubo, T; Kitamura, M; Mitsumori, N; Nakazawa, Y | 1 |
| Fujitani, K; Furukawa, H; Imamura, H; Imano, M; Kimura, Y; Kurokawa, Y; Matsuoka, M; Shimokawa, T; Takiuchi, H; Tokunaga, Y; Tsujinaka, T; Yano, H | 1 |
2 trial(s) available for paclitaxel and Hypoalbuminemia
| Article | Year |
|---|---|
Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer.
Topics: Aged; Albumin-Bound Paclitaxel; Albumins; Antineoplastic Combined Chemotherapy Protocols; Edema; Female; Gemcitabine; Humans; Hypoalbuminemia; Male; Paclitaxel; Pancreatic Neoplasms | 2023 |
A phase I study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 in patients with advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Fatigue; Female; Humans; Hypoalbuminemia; Hypokalemia; Hyponatremia; Male; Middle Aged; Neoplasm Staging; Neutropenia; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur; Treatment Outcome | 2013 |
3 other study(ies) available for paclitaxel and Hypoalbuminemia
| Article | Year |
|---|---|
Baseline Factors Predictive of the Receipt of Second-Line Chemotherapy After Nab-Paclitaxel Plus Gemcitabine for Patients With Advanced Pancreatic Cancer.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Hypoalbuminemia; Paclitaxel; Pancreatic Neoplasms; Retrospective Studies; Sarcopenia | 2022 |
The correlation between paclitaxel chemotoxicity and the plasma albumin level in cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Hypoalbuminemia; Neoplasms; Paclitaxel; Serum Albumin | 2022 |
[Effect of Hypoalbuminemia on Severe Neutropenia Induced by Paclitaxel Monotherapy and Paclitaxel plus Ramucirumab Combination Therapy in Patients with Gastric Cancer].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Humans; Hypoalbuminemia; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Ramucirumab; Stomach Neoplasms | 2019 |